[Interstitial lung disease and connective tissue diseases]

Area of Science:

• Rheumatology
• Pulmonology
• Immunology

Context:

• Lung involvement is a common complication in rheumatologic diseases, presenting diverse clinical and radiological features.
• Differentiating rheumatologic lung disease from infections or pulmonary hypertension is crucial for accurate diagnosis and management.
• Interstitial lung disease (ILD) is a significant manifestation within rheumatologic conditions.

Purpose:

• To emphasize the need for detailed work-up and multidisciplinary evaluation in patients with rheumatologic diseases and lung involvement.
• To highlight key factors influencing treatment decisions, including disease severity, activity, presentation, and comorbidities.
• To address the limited evidence guiding optimal immunosuppressive therapy for rheumatologic-associated ILD.

Summary:

• Rheumatologic lung diseases exhibit a wide range of presentations, from acute inflammation to chronic fibrosis.
• Comprehensive assessment is vital to exclude other causes of pulmonary decline, especially in immunosuppressed patients.
• Treatment strategies for rheumatologic ILD are individualized, considering multiple clinical parameters, but robust therapeutic evidence remains scarce.

Impact:

• Improved diagnostic accuracy for lung involvement in rheumatologic conditions.
• Enhanced patient management through tailored, multidisciplinary approaches.
• Identification of knowledge gaps to stimulate further research into optimal therapies for rheumatologic ILD.